TheraRadar
Clinical-Stage Companies / BioDelivery Sciences

BioDelivery Sciences

Pre-Approval PRO BETA

Inactive Company

No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 7/23/2019

16
Total Trials
9
Phase 3
6
Phase 2
0
Recruiting
186
Score

Pipeline by Phase

Phase 3
9
Phase 2
6
Phase 1
1

Therapeutic Focus

Low Back Pain Pain Painful Diabetic Neuropathy Migraine Headache Respiratory Depression

Clinical Trials (16)

NCT03006276 Phase 3 COMPLETED

Efficacy, Tolerability, and Safety Study of DFN-15

Started: 12/1/2016

NCT03009019 Phase 3 COMPLETED

Efficacy, Tolerability, and Safety of DFN-15

Started: 12/1/2016

NCT00696137 Phase 3 COMPLETED

Long-term Extension Study of BEMA™ Fentanyl

Started: 6/1/2008

NCT01755546 Phase 3 COMPLETED

Long-term Open-Label Safety Study to Evaluate EN3409

Started: 12/1/2012

NCT01298765 Phase 3 COMPLETED

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain

Started: 3/1/2011

NCT01633944 Phase 3 COMPLETED

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects

Started: 8/1/2012

NCT01675167 Phase 3 COMPLETED

Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects

Started: 9/1/2012

NCT01256450 Phase 3 COMPLETED

Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain

Started: 11/1/2010

NCT01431742 Phase 3 WITHDRAWN

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain

Started: 7/1/2012

NCT02068027 Phase 2 COMPLETED

Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy

Started: 3/1/2014

NCT02643251 Phase 2 COMPLETED

The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy

Started: 12/1/2015

NCT02355158 Phase 2 COMPLETED

A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy

Started: 6/1/2014

NCT01666119 Phase 2 COMPLETED

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

Started: 8/1/2012

NCT00941304 Phase 2 COMPLETED

Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain

Started: 8/1/2009

NCT01871285 Phase 2 COMPLETED

Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film

Started: 6/1/2013

NCT03996694 Phase 1 COMPLETED

Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.

Started: 7/23/2019

Drug Candidates

DFN-15 Active Belbuca 300 µg Belbuca 600 µg Belbuca 900 µg Oxycodone 30 mg Oxycodone 60 mg Placebo BEMA Fentanyl EN3409 BEMA Buprenorphine
Activity Status: Inactive
Last Trial Started: 7/23/2019
Last Trial Ended: 10/27/2019
Trials (12 months): 0
Completed Trials: 15
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.